POSC256 Application of Progression-Free Survival As Surrogate Endpoint for Overall Survival in Nice Reviews of Advanced Breast Cancer Drugs
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.894
https://www.valueinhealthjournal.com/article/S1098-3015(21)02689-9/fulltext
Title :
POSC256 Application of Progression-Free Survival As Surrogate Endpoint for Overall Survival in Nice Reviews of Advanced Breast Cancer Drugs
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02689-9&doi=10.1016/j.jval.2021.11.894
First page :
Section Title :
Open access? :
No
Section Order :
10421